When: Close above $509.53-510 with MACD histogram contracting

Then: Upgrade toward Overweight, add 1% tranche at $510

REDUCE INITIAL SIZING to 1% maximum on confirmed technical stabilization; require staged entry with strict technical triggers before adding a second tranche; hold maximum position size to 2% until pullback to $465-$490 zone or confirmed breakout above $509; maintain hard stop at $489.

• Technical picture shows 6.5% drawdown over two weeks with MACD below zero, 10-day EMA rolling over, and stock unable to reclaim $5.05 on any of last 7 sessions—suggesting breakdown rather than consolidation
• Forward P/E of 22.76x reflects operating earnings compression, not mark-to-market artifact; 8% upside to intrinsic value ($500-$540) vs ~1.6% downside to 200 SMA at $492
• Cash hoard of $373B generates ~$17B interest but does not protect against mark-to-market losses on $359B equity portfolio or Alphabet's $205B capex commitment on $37.8B position
• Berkshire management declined buyback in 2025—a signal from those who know intrinsic value best that $500 offers no margin of safety
• 60% concentration in 5 mega-cap names creates synchronous macro exposure; Taylor Morrison $6.8B deal adds housing cycle risk at potentially wrong time
• Institutional sentiment is genuinely mixed at 5.2/10 with explicit bearish coverage on concentration, housing, and Alphabet capex; retail sentiment data is absent and uninformative
• Probability of reaching $540 target estimated at 30-40% given technical posture vs 25-30% probability of hitting $489 stop, yielding expected value closer to 1.4:1 rather than 4:1

→ vs aggressive: Base-building pattern is indistinguishable from topping pattern until after the fact; stock has failed at $5.29 and stalled at ~$5.05 for 7 sessions without breaking higher on compressed volume

→ vs aggressive: Forward P/E of 22.76x reflects genuine operating earnings compression, not temporary noise; cherry-picking trailing P/E of 12.69x is intellectually dishonest

→ vs aggressive: Cash hoard does not protect equity investors from mark-to-market losses on the $359B equity portfolio or concentration risk in Alphabet at $37.8B with $205B capex commitment

→ vs aggressive: Management declining buybacks at $500 is a message, not optionality preservation; ignores signal from those who know intrinsic value best

→ vs aggressive: Sum-of-parts intrinsic value hand-waving traps investors in stories rather than businesses; entry at bottom of $500-$540 range leaves only 8% upside

→ vs aggressive: Stop-loss logic inverts risk-reward: 30-40% probability of reaching $540 vs 25-30% probability of hitting $489 stop yields ~1.4:1 expected value, not 4:1

→ vs aggressive: Retail sentiment absence is not data and cannot support a directional thesis; institutional sentiment at 5.2/10 reflects genuine bearish concerns

MODIFIED BUY: Initiate 1% at $500, add 0.5% at $495-500 if 10 EMA stabilizes, add final 0.5% only if $489 holds with RSI above 45, hard stop at $489 with no exceptions; add another 1% on close above $505 with rising RSI as confirmation; maximum position 2.5% until Berkshire resumes buybacks, housing thesis shows evidence, or market dislocation creates $465-480 entry zone.

• MACD crossed below zero with histogram expanding negative for six consecutive sessions — confirmed momentum shift, not noise
• 10 EMA actively declining from peak around $516.61 down to $504.05
• Every bounce attempt stalled within a dollar of $505 for a full week — pattern of equal lows and equal highs, not accumulation
• Current price represents fair value, not a screaming buy — buyback pause signals Abel in active deployment mode, not Buffett signaling overvaluation
• Scaled entry framework is structurally correct but position size should be more moderate than aggressive analyst wants
• Add-on trigger: simple close above $505 with rising RSI rather than restrictive $508.91 with full momentum confirmation
• Conservative analyst's entry framework is too restrictive for defensive compounders — momentum confirmation entries don't work for quality compounders where the point is buying at reasonable prices
• Maximum 2.5% total position until one of three catalysts: Berkshire resumes buybacks, housing thesis shows clearer evidence, or market dislocation creates $465-480 zone
• Upside target remains $540 but requires multiple expansion event, major acquisition, buyback resumption, or broad market melt-up — none imminent

→ vs aggressive: Technical consolidation argument is the weakest pillar — MACD crossed below zero with six consecutive sessions of expanding negative histogram, 10 EMA actively declining from $516.61 to $504.05, and every bounce has stalled within a dollar of $505, showing equal lows not higher lows

→ vs aggressive: Reward-to-risk math is flawed — 3.6:1 nominal ratio assumes 60% probability of hitting $540, but if probability is 35-40% as conservative analyst argues, expected value is break-even at best; $540 is upper bound of fair value range requiring multiple expansion or acquisition, not a guaranteed target

→ vs aggressive: Too dismissive of buyback pause signal — while not definitive overvaluation, combined with technical posture, housing cycle exposure, Alphabet concentration, and elevated forward P/E, it forms a pattern indicating this is not a screaming buy at this moment

→ vs conservative: Entry framework applies tactical trader's framework to strategic compounder — waiting for daily close above $508.91 with full momentum confirmation likely means entry at $515-$520, giving up 3% upside for 'confirmation' that delivers worse risk-adjusted returns for defensive compounders

→ vs conservative: $465-480 entry zone requires 7-9% pullback via market-wide correction or Berkshire-specific dislocation — structurally unlikely given Polymarket pricing 8% recession probability and Berkshire's cash hoard providing downside support; waiting months means missing structural compounding engine

→ vs conservative: Five-to-one downside-to-upside framing is selectively applied — $489 isn't a hard floor, it's a confluence zone with 200 SMA at $492.41 and Bollinger lower band at $489.68; worst-case downside is $36 to March-April lows around $464, not $11